Sort by
Keyphrases
Corneal Neovascularization
100%
Corneal Epithelium
33%
Drug Accumulation
24%
Nanoparticles
24%
SAFE Strategy
24%
Eye Drops
22%
Indocyanine Green
21%
Lacrimal Gland
21%
SU6668
20%
Blood Vessels
17%
Neovascularization
16%
Theranostics
16%
Photoacoustic Imaging
16%
Ocular Surface
16%
Anti-vascular Endothelial Growth Factor (anti-VEGF)
15%
Therapeutic Effect
14%
Anti-VEGF Therapy
14%
Phototherapy
14%
Antioxidant
14%
Nanomedicine
12%
Cornea
12%
Lacrimal Duct
12%
Microbiota Modulation
12%
Ectodysplasin
12%
Microenvironment Change
12%
Peptic Ulcer Disease
12%
Oxidant-antioxidant Balance
12%
Mouse Model
12%
Efficient Strategy
12%
Severe Dry Eye
12%
Biomimetic
12%
Electroacupuncture
12%
Synergistic Therapy
12%
Homeostasis
12%
Nanocomplex
12%
In Vivo Assembly
12%
Ophthalmic Diseases
12%
Fuchs Endothelial Corneal Dystrophy
12%
Selective Strategy
12%
P38 Mitogen-activated Protein Kinase (p38 MAPK)
12%
Imaging-guided
12%
Drug Delivery Strategies
12%
Laser Therapy
12%
Therapeutic Strategies
12%
Non-invasive Strategies
12%
Drug Permeation
12%
Tissue-engineered Constructs
12%
Drug Delivery System
12%
Ultrasmall Nanoparticles
12%
Therapy Strategy
12%
Medicine and Dentistry
Corneal Neovascularization
62%
Corneal Epithelium
31%
Nanoparticle
29%
Antioxidant
24%
Vasculotropin
24%
Lacrimal Gland
23%
Photoacoustic Imaging
18%
Ocular Surface
17%
Stem Cell
16%
Phototherapy
16%
Downregulation
15%
Meibomian Gland
15%
Suture
15%
Homeostasis
14%
Drug Therapy
14%
Meibomian Gland Dysfunction
13%
Vascular Bundle
13%
Corneal Ulcer
12%
Autoimmunity
12%
Ectodysplasin A
12%
Drug Accumulation
12%
Orantinib
12%
Kinase Signaling
12%
Mitogen Activated Protein Kinase P38
12%
Electroacupuncture
12%
Dry Eye
12%
Obstruction
12%
Oxidizing Agent
12%
Engineered Tissue
12%
Jejunum Ulcer
12%
Cell Signaling Pathway
12%
Curettage
12%
Fuchs Endothelial Corneal Dystrophy
12%
Optical Coherence Tomography Angiography
12%
Conbercept
12%
Cornea Rodent Ulcer
12%
Secretion (Process)
12%
Raman Spectrometry
12%
Nanomedicine
11%
Visual Impairment
11%
Immunofluorescence
6%
Small Interfering RNA
6%
Glucose Oxidase
6%
Angiogenesis
6%
Eye Disease
6%
Aflibercept
6%
Bevacizumab
6%
Ranibizumab
6%
Pegaptanib
6%
Eye Injury
5%
Pharmacology, Toxicology and Pharmaceutical Science
Cornea Neovascularization
82%
Nanoparticle
46%
Elimination
28%
Antioxidant
24%
Vasculotropin
24%
Neovascularization (Pathology)
22%
Pharmacotherapy
21%
Orantinib
20%
Nanomedicine
15%
Diseases
13%
Cornea Dystrophy
12%
Synergistic Therapy
12%
Indocyanine Green
12%
Oxidizing Agent
12%
Electroacupuncture
12%
Agents Acting on the Eye
12%
Jejunum Ulcer
12%
Peptic Ulcer
12%
Microflora
12%
Drug Delivery System
12%
Conbercept
12%
Meibomian Gland Dysfunction
12%
Visual Impairment
11%
Therapeutic Effect
10%
Hyperthermia
8%
Age Related Macular Degeneration
7%
Bioavailability
6%
Protein Tyrosine Kinase
6%
Side Effect
6%
Small Interfering RNA
6%
Glucose Oxidase
6%
Ranibizumab
6%
Aflibercept
6%
Pegaptanib
6%
Bevacizumab
6%
